CHARACTERIZATION OF A LITHIUM FORMATE EPR-DOSIMETRY SYSTEM FOR PROTON RADIATION THERAPY.


Journal

Radiation protection dosimetry
ISSN: 1742-3406
Titre abrégé: Radiat Prot Dosimetry
Pays: England
ID NLM: 8109958

Informations de publication

Date de publication:
31 Dec 2019
Historique:
received: 25 08 2018
revised: 25 11 2018
pubmed: 10 1 2019
medline: 5 8 2020
entrez: 10 1 2019
Statut: ppublish

Résumé

The specific aim for the characterization of the lithium formate dosimetry system is to determine response and stability in a proton beam. The long-term goal for this investigation is an audit system for proton therapy like the end-to-end dose determinations performed for radiotherapy with photons. For a 150-MeV proton beam, the dose response was found to be linear in the dose interval 0-8.8 Gy. The accuracy of dose reconstruction was controlled in a blind test, in which the dose of 6.63 Gy was measured in samples irradiated with a real dose of 6.70 Gy. The stability was determined by irradiations of sets of four dosimeters every week during 1 month and analyzed at the same day thereafter. The fitting of the fading curve was done with a second-order polynomial resulting in a 6.6% lower value compared to the reference after 31 d.

Identifiants

pubmed: 30624734
pii: 5281159
doi: 10.1093/rpd/ncy293
doi:

Substances chimiques

Formates 0
formic acid 0YIW783RG1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-87

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

T Costa (T)

Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

E Adolfsson (E)

Department of Medical Physics and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

M Fager (M)

Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.

E Lund (E)

Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH